ANNE VIET-ANH HORGAN,EDWARD SAVORY,KATHRYN OLIVER,MICHAEL HIGGINBOTTOM
申请号：
BRPI0918602
公开号：
BRPI0918602A2
申请日:
2009.09.16
申请国别(地区):
BR
年份:
2015
代理人:
摘要：
and their pharmaceutically acceptable salts, solvates, hydrates, geometrical isomers, tautomers, optical isomers or N-oxides, which are inhibitors of SSAO activity. The invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the treatment of medical conditions wherein inhibition of SSAO activity is beneficial, such as inflammatory diseases and immune disorders.
